Top-News

Reneuron Group News

Keine aktuellen Kursdaten verfügbar
WKN: A0JLYM
ISIN: GB00B0DZML60
Typ: Aktie

Reneuron Group News

29.06.20 - PR Newswire
ReNeuron Announces Further Positive Data in Retinal Clinical Trial
ReNeuron Announces Further Positive Data in Retinal Clinical Trial Further long-term data demonstrate continuing, clinically meaningful efficacy at all time-​points measured out to ...
25.06.20 - PR Newswire
ReNeuron Signs New Exosome Research Collaboration
ReNeuron Signs New Exosome Research Collaboration PR Newswire
17.06.20 - PR Newswire
ReNeuron Provides Program and Regulatory Approvals Update
ReNeuron Provides Program and Regulatory Approvals Update PR Newswire
07.04.20 - PR Newswire
ReNeuron Announces Exosome Research Collaboration
ReNeuron Announces Exosome Research Collaboration PR Newswire
06.04.20 - PR Newswire
ReNeuron Update Regarding COVID-19
ReNeuron Update Regarding COVID-19 PR Newswire
24.02.20 - PR Newswire
ReNeuron Announces Positive Long-term Data in Retinal Clinical Trial
ReNeuron Announces Positive Long-term Data in Retinal Clinical Trial Meaningful clinical effect observed in patients out to 12 months post-​treatment Expansion of ongoing Phase ...
18.02.20 - PR Newswire
ReNeuron Announces Publication of Positive Phase 2a Stroke Clinical Data
ReNeuron Announces Publication of Positive Phase 2a Stroke Clinical Data PR Newswire
23.10.19 - PR Newswire
ReNeuron Presents Positive Data at the 27th Annual Congress of the European Society of Gene and Cell Therapy on Lead Cell Line
ReNeuron Presents Positive Data at the 27th Annual Congress of the European Society of Gene and Cell Therapy on Lead Cell Line New data show ReNeuron's lead CTX cell ...
14.10.19 - PR Newswire
ReNeuron Presents Positive Clinical Data at the American Academy of Ophthalmology Annual Meeting
ReNeuron Presents Positive Clinical Data at the American Academy of Ophthalmology Annual Meeting Study investigator presents positive efficacy data in ongoing retinal disease ...
02.10.19 - PR Newswire
ReNeuron Announces Clinical Update and Conference Presentations
ReNeuron Announces Clinical Update and Conference Presentations "Clear efficacy signal" in Phase 2a study of hRPC cell therapy in retinitis pigmentosa PR Newswire
16.07.19 - PR Newswire
ReNeuron Expands Exosome IP Portfolio with Key Patent Grants
ReNeuron Expands Exosome IP Portfolio with Key Patent Grants PR Newswire
31.05.19 - PR Newswire
ReNeuron to Participate in the Jefferies 2019 Global Healthcare Conference
ReNeuron to Participate in the Jefferies 2019 Global Healthcare Conference PR Newswire
08.05.19 - PR Newswire
ReNeuron Provides Business Update and Results Notification
ReNeuron Provides Business Update and Results Notification Second Cohort of Phase 2a Study in Retinitis Pigmentosa Dosing Complete PR Newswire
26.04.19 - PR Newswire
ReNeuron Announces Presentation of Updated Efficacy and Safety Data from Retinitis Pigmentosa Study at the Sixth Annual Retinal Cell and Gene Therapy Innovation Summit
ReNeuron Announces Presentation of Updated Efficacy and Safety Data from Retinitis Pigmentosa Study at the Sixth Annual Retinal Cell and Gene Therapy Innovation Summit ...
09.04.19 - PR Newswire
ReNeuron Partners with Fosun Pharma in China
ReNeuron Partners with Fosun Pharma in China ReNeuron licenses rights to its CTX and hRPC cell therapy programmes to Fosun Pharma for Chinese market ReNeuron to ...
05.04.19 - PR Newswire
ReNeuron to Present at the H.C. Wainwright Global Life Sciences Conference
ReNeuron to Present at the H.C. Wainwright Global Life Sciences Conference PR Newswire
18.03.19 - PR Newswire
ReNeuron Announces Retinal Clinical Trial Progresses to Next Stage
ReNeuron Announces Retinal Clinical Trial Progresses to Next Stage PR Newswire
18.03.19 - PR Newswire
ReNeuron to Present at the Alliance for Regenerative Medicine's Cell & Gene Therapy Investor Day
ReNeuron to Present at the Alliance for Regenerative Medicine's Cell & Gene Therapy Investor Day PR Newswire
20.02.19 - PR Newswire
ReNeuron Group plc Announces Positive Preliminary Data in U.S. Retinitis Pigmentosa Trial
ReNeuron Group plc Announces Positive Preliminary Data in U.S. Retinitis Pigmentosa Trial hRPC Cell Therapy Demonstrates Significant Restoration of Vision in First Cohort of ...

Newssuche

Videos

newspaper
08:40 Uhr +11,66%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »